3188 results for cancer and finances
Refine Your Search
A phase 2 expansion study of ICT01, an anti-BTN3A monoclonal antibody, in combination with azacitidine and venetoclax in patients with AML
In June , LLS made an equity investment in ImCheck Therapeutics to "Support Clinical Development of the ICT01 Program for Blood Cancer Indications."Im…
Blood Cancer Support Group (West Los Angeles) - 1st Wednesday
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
Blood Cancer Support Group (West Los Angeles) - 1st Wednesday
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
Blood Cancer Support Group (West Los Angeles) - 3rd Wednesday
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
Blood Cancer Support Group (West Los Angeles) - 3rd Wednesday
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
Identifying Prognostic Markers of Relapse in Hairy Cell Leukemia (HCL) and HCL-Variant by Profiling Mutated Blood Stem Cells and Fibrosis Pathways
This collaborative program investigates why Hairy Cell Leukemia (HCL) and its variant often relapse despite effective therapies and why fibrosis freq…
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
SAN DIEGO, Feb. , - Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. today announced positive topline results from , the Phase trial of ziftomenib, a …
News Release
A Phase I/II Study of the Combination of ALX148, Rituximab and Lenalidomide in Patients with Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
SIRPα+ macrophages mediate resistance to lenalidomide in lymphoma, limiting the activity of immunotherapy for these patients. Therefore, we propose a…
Suggested Reading - Know Your Enemy: A Guidebook For Your Cancer Journey
If you or a loved one has ever been on the receiving end of this diagnosis, you know instantly that your life will never be the same. Know Your Enemy …
How to brighten holidays in the hospital for cancer patients
Cancer treatment doesn’t pause for the holidays. While the world outside is filled with lights and laughter, inside the hospital walls, patients are o…
Blog
Blood Cancer United Awards Recognize Individuals for Excellence in Scientific Research & Service to the Blood Cancer Community
WASHINGTON, Dec. , – Thanks to an array of scientific advances, more people who are diagnosed with blood cancer today will be cured than ever before.…
News Release
Research: Grants
Research: TAP
Epigenetic heterogeneity in age-related clonal hematopoiesis and acute myeloid leukemia
Our focus is to unravel how clonal hematopoiesis (CH) progresses to leukemia. We will investigate how epigenetic heterogeneity affects Tet2-mutant hem…
Novel targeted therapies for acute myeloid leukaemia and multiple myeloma
Outcomes for acute myeloid leukemia (AML) and multiple myeloma (MM) patients remain inadequate and new treatment options to combat resistance against …
Cotargeting oncogenic protein translation and apoptosis in acute myeloid leukemia
The focus of my research is to evaluate the efficacy of and to unravel the molecular mechanisms underpinning a novel drug combination in AML targeting…
Largest Healthcare Cuts in History Passed by House and Senate
Blood Cancer United strongly condemns the bill, which puts cancer patients at risk
News Release
Chimeric antigen receptor (CAR) T-cell therapy for children and teens
Autologous CAR immunotherapy uses a person’s own immune cells (T cells) to identify and attack cancer cells.
Support Resources
Revisiting splicing factor mutations in MDS/AML – delving deep and wide
This project aims to uncover how obligatory heterozygous mutant splicing factors (SF) impact their wildtype counterparts’ functions, RNA interaction s…
Affordable Care Act (ACA) patient protections for children and teens
In plans that adhere to the ACA, you cannot be denied coverage or charged a higher premium for coverage due to any condition, including cancer.
Support Resources
Infections, low blood counts, and iron overload in young adults
Blood cancer treatment can make patients susceptible to low blood counts and infections, which may be serious and difficult to treat.
Support Resources
Understanding the clonal origin, evolution, and progression of myeloid malignancies
The overarching focus of my research is to understand the clonal origin, evolution, and progression of myeloid malignancies and biological and clinica…
Understanding and Overcoming Mechanisms of Immune Evasion after Allogeneic Transplant
Outcomes for patients with acute myelogenous leukemia who relapse after transplantation are dismal. This SCOR brings together an international group o…
Modeling and targeting leukemic transformation of human hematopoietic stem cells
Our research seeks to understand how ordered acquisition of oncogenic mutations transforms human hematopoietic stem cells into myeloid malignancies. W…
Kelsey and the Yellow Kite: A Book for Children About Myeloma
This book has been written to help explain what myeloma is to children and teenagers. Kelsey and the Yellow Kite tells the story of a little girl call…
BAFF-ligand CAR T-cells and pre-apheresis B-cell lymphodepletion for relapsed/refractory CLL
Most CLL patients treated with CAR that target the CD19 antigen on the cell do not achieve a complete remission. CLL cells express other molecules on…
Research: Grants